Lou Carlozo

Lou Carlozo

InvestorPlace Contributor

Lou Carlozo is Editor In Chief at Qwoted, a source platform for finance journalists, and host/creator of Bankadelic, a financial services podcast. Through 2019, he served as managing editor at the Bank Administration Institute and an investment writer at U.S. News & World Report. A Pulitzer Prize finalist (team reporting), his work has appeared in Reuters, the Chicago Tribune, Los Angeles Times, Yahoo Finance, MSN and publications across the world; his multi-media journalism credits include BBC radio, Investigation Discovery TV, AOL and an Archie cartoon where he appeared as himself. Lou is also a professional musician, producer/composer and recording studio owner. He resides in Chicago with his wife and two children.

Recent Articles

Get Ready for Ford Stock to Gun Its Engines

By Lou Carlozo, InvestorPlace Contributor

Ford stock has the goods. The herds that reek of FOMO and chase after ride-hailing losers and overhyped IPOs will learn this in time, I think.

It’s Time to Admit That Marathon Oil Stock Is a Perennial Disappointment

By Lou Carlozo, InvestorPlace Contributor

MRO stock is a buy-and-hold cellar dweller. Short term, its boost comes largely from amateur investors and fickle adrenaline junkies who will skip off to the next hot thing like flies on sherbet. And overall, it belongs to a moribund sector made up of corporations that have no place in the smart future of ESG investing.

Hertz Stock May See Some Post-Pandemic Daylight

By Lou Carlozo, InvestorPlace Contributor

The appearance of several Covid-19 vaccines will likely revitalize the travel industry and everything around it, which means the calculus is simple. If more people take to the skies and on road trips again, more will rent cars.

Bitcoin Has Portfolio Potential Despite High Price and Wild Speculation

By Lou Carlozo, InvestorPlace Contributor

You may well ride a wave where the current price of bitcoin hits near $50,000 in 2021, the high end of a Bloomberg forecast. Then again, they also argue for a low-end of the range at $10,000.

Novavax Stock a Strong Bet to Ride the Vaccination Wave

By Lou Carlozo, InvestorPlace Contributor

Novavax is in Phase 3 trials with its novel coronavirus vaccine and success there will provide massive momentum for NVAX stock.

Load More